Islet Sheet Medical aims to make the most effective use of our medical team, collaborators, advisors and friends.

Collaborators

Jonathan Lakey

University of Alberta Edmonton, Alberta Canada
E-mail: Jonathan.Lakey@ualberta.ca

Jonathan Lakey, Ph.D., age 35, is an Associate Professor at the University of Alberta, Comprehensive Tissue Centre, Departments of Surgery Laboratory Medicine & Pathology. He is the supervisor of islet isolation for the clinical research program at the University of Alberta. He and Dr. Shapiro will be supervising the Company?s canine Islet Sheet studies at the University of Alberta. His pioneering work on development of methods for islet isolation formed the background to the current success of the Edmonton Group in 14 patients who have remained off insulin for longer than one year.

Horacio L. R. Rilo, MD

University of Cincinnati
Cincinnati OH

E-mail: RILOHL@UCMAIL.UC.EDU

Horacio L. Rodriguez Rilo received his MD from the University of Buenos Aires School of Medicine in Argentina where he also completed his Residency in General Surgery. He did a fellowship in Liver Transplantation at the Liver Unit at the University of Sao Paulo, Brazil. He was a Fellow and Visiting Assistant Professor of Surgery at the University of Pittsburgh. He was Assistant Professor of Surgery at the University of Chicago and Director of Cellular Transplantation. He is now Associate Professor of Surgery and Pediatrics at the University of Cincinnati School of Medicine and Children's Hospital and Director of Cellular Transplantation. His research focus is in new Strategies for Immunoisolation of Pancreatic Islets. He will be Principal Investigator at the University of Cincinnati, responsible for islet isolation and Islet Sheet implantation research for the Islet Sheet Medical project.

James Shapiro

University of Alberta Edmonton, Alberta Canada

James Shapiro, M.D. is the Director and Head of the Clinical Islet Transplant Program at the University of Alberta in Edmonton, Canada. He is a transplant surgeon who conducted extensive research in islet transplantation in the laboratory that formed the background to the current success of the Edmonton Group in 14 patients who have remained off insulin for longer than one year. He is the lead author of a recent paper in The New England Journal of Medicine showing successful transplantation of seven type 1 diabetics at the University of Alberta. He received an M.D. from the University of Newcastle and trained in Surgery in England.